Standard Biotools (LAB) Non-Current Deferred Tax Liability (2014 - 2026)
Standard Biotools (LAB) posted quarterly Non-Current Deferred Tax Liability of $823000.0 for Q1 2026, down 20.17% year-over-year from $1.0 million in Q1 2025, and up 1.6% quarter-over-quarter from $810000.0 in Q4 2025.
Standard Biotools (LAB) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Non-Current Deferred Tax Liability for 13 consecutive years, with $823000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 20.17% year-over-year to $823000.0; the TTM figure through Mar 2026 stood at $823000.0 (down 20.17% YoY), while the FY2025 annual figure was $810000.0, down 89.53% from the prior year.
- Non-Current Deferred Tax Liability grew to $823000.0 in Q1 2026 per LAB's latest filing, from $810000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $7.7 million in Q4 2024 and bottomed at $620000.0 in Q3 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $1.5 million across 5 years, with a median of $1.0 million in 2025.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability plunged 91.42% — and 2024, when it soared 820.33%.
- Standard Biotools' Non-Current Deferred Tax Liability stood at $1.1 million in 2022, then dropped by 20.28% to $841000.0 in 2023, then jumped by 820.33% to $7.7 million in 2024, then slumped by 89.53% to $810000.0 in 2025, then grew by 1.6% to $823000.0 in 2026.
- Business Quant data shows LAB's Non-Current Deferred Tax Liability at $823000.0 in Q1 2026, $810000.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 823,000.00 |
| Jun 30, 2026 | 823,000.00 |
| Mar 31, 2026 | 823,000.00 |
| Mar 31, 2026 | 823,000.00 |
| Dec 31, 2025 | 810,000.00 |
| Dec 31, 2025 | 810,000.00 |
| Sep 30, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Sep 30, 2024 | 841,000.00 |
| Sep 30, 2024 | 841,000.00 |
| Jun 30, 2024 | 841,000.00 |
| Jun 30, 2024 | 841,000.00 |
| Mar 31, 2024 | 841,000.00 |
| Mar 31, 2024 | 841,000.00 |